Qi Lu Wan Bao Wang·2025-07-09 15:35Group 1 - The 42nd National Pharmaceutical Industry Information Annual Conference was held in Beijing from July 5 to 7, organized by the China Pharmaceutical Industry Information Center, which released the list of the top 100 companies by main business revenue for 2024 [1] - China National Pharmaceutical Group continues to rank first, followed by China Resources Pharmaceutical and Qilu Pharmaceutical in second and third places respectively [1] - The conference theme was "Exploring Life, Co-creating the Future," focusing on cutting-edge technology, industrial ecology, and capital empowerment to outline a development blueprint for the Chinese pharmaceutical health industry [1] Group 2 - The pharmaceutical industry in Zibo has over 70 years of development history, forming a comprehensive industrial system that includes drug formulations, active pharmaceutical ingredients, medical devices, and traditional Chinese medicine [2] - In 2024, Zibo's pharmaceutical industry is projected to achieve a revenue of 65 billion yuan with double-digit growth, demonstrating strong industry resilience and development potential [2] Group 3 - Shandong Xinhua Pharmaceutical Co., Ltd. ranked 37th, Ruiyang Pharmaceutical Co., Ltd. ranked 77th, Shandong Qidu Pharmaceutical Co., Ltd. ranked 83rd, and Shandong Jincheng Pharmaceutical Group Co., Ltd. ranked 96th in the top 100 list [1] - Compared to the previous year's rankings, Xinhua Pharmaceutical improved by 3 positions, Ruiyang Pharmaceutical dropped by 14 positions, Qidu Pharmaceutical improved by 4 positions, and Jincheng Pharmaceutical dropped by 5 positions [1]